What is Desjardins’ Estimate for TSE:INO FY2025 Earnings?

Inovalis Real Estate Investment Trust (TSE:INO) – Equities research analysts at Desjardins increased their FY2025 EPS estimates for shares of Inovalis Real Estate Investment Trust in a report released on Wednesday, April 2nd. Desjardins analyst A. Leon now forecasts that the company will post earnings of $0.06 per share for the year, up from their previous estimate of ($0.06). Desjardins also issued estimates for Inovalis Real Estate Investment Trust’s FY2026 earnings at ($0.02) EPS.

Inovalis Real Estate Investment Trust Stock Performance

About Inovalis Real Estate Investment Trust

Inovio Pharmaceuticals, Inc, a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids.